<i>Clostridioides difficile</i> and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia

<i>Clostridioides difficile</i> and Vancomycin-Resistant Enterococci in COVID-19 Patients with Severe Pneumonia

Broad-spectrum antibiotics administered to patients with severe COVID-19 pneumonia pose a risk of infection caused by <i>Clostridioides difficile</i>. This risk is reduced mainly by strict hygiene measures and early de-escalation of antibiotic therapy. Recently, oral vancomycin prophylax...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kateřina Bogdanová, Lenka Doubravská, Iva Vágnerová, Kristýna Hricová, Vendula Pudová, Magdaléna Röderová, Jan Papajk, Radovan Uvízl, Kateřina Langová, Milan Kolář
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
COVID-19
<i>Clostridioides difficile</i>
oral vancomycin prophylaxis
vancomycin-resistant enterococci
molecular typing of VRE
ICU
Science
Q
Acceso en línea:https://doaj.org/article/d70a4399caf749338b4fdd4b797431ff
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares